Effect of pulegone on the NLPR3 inflammasome during inflammatory activation of THP‑1 cells

Yang,Qingxin; Liu,Qi; Lv,Hongjun; Wang,Feng; Liu,Rong; Zeng,Nan

doi:10.3892/etm.2019.8327

Effect of pulegone on the NLPR3 inflammasome during inflammatory activation of THP‑1 cells

Authors:
- Qingxin Yang
- Qi Liu
- Hongjun Lv
- Feng Wang
- Rong Liu
- Nan Zeng
View Affiliations

Affiliations: Department of Pharmacology, College of Pharmacy, Chengdu University of TCM, Chengdu, Sichuan 611137, P.R. China
Published online on: December 13, 2019 https://doi.org/10.3892/etm.2019.8327
Pages: 1304-1312
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pulegone is a key active component of Schizonepeta essential oil and has been determined to have anti‑inflammatory properties. However, the underlying molecular mechanisms with regard to the NLR family pyrin domain containing 3 (NLRP3) inflammasome, also known as the NALP3 inflammasome, have remained to be elucidated. NLRP3 represents a potential link between inflammation and immunity and may play possible key role in various pathologies. In the present study, the modulatory effects of pulegone on the NLRP3 inflammasome were investigated. THP‑1 cells induced with phorbol myristate acetate were divided into various groups, including the Normal (control), lipopolysaccharide (LPS), LPS + ATP/nigericin, LPS + ATP/nigericin + 0.2% DMSO and pulegone (0.2, 0.1 and 0.05 mg/ml) groups. ELISA was used to detect the levels of interleukin (IL)‑1β and IL‑18 in the cell supernatants and the influence of potassium ions was assessed. PCR was used to determine the expression levels of NLRP3, caspase‑1, IL‑1β and IL‑1α in the cell lysates. Furthermore, NLRP3 and apoptosis‑associated speck‑like protein (ASC) were detected via immunofluorescence assays and fluorescence microscopy was employed to determine the reactive oxygen species (ROS) levels in the THP‑1 cells. The results indicated reduced levels of IL‑18 and IL‑1β in the supernatant of the cells of the pulegone groups when compared with those in the LPS + ATP/nigericin group. In addition, reduced mRNA production of inflammasome‑associated genes was detected in the cell lysates after pulegone treatment. The immunoﬂuorescence analyses indicated significantly reduced protein expression levels of NLRP3 and ASC in the pulegone groups, as well as co‑localization of the NLRP3 and ASC proteins. The pulegone groups also exhibited significantly reduced ROS levels. Furthermore, a high concentration of potassium ions significantly reduced the secretion of IL‑1β after induction/stimulation. In conclusion, the present study suggested that pulegone exerts its anti‑inflammatory effects on LPS + ATP/nigericin‑induced THP‑1 cells via inhibition of NLRP3 expression, and its regulatory mechanism is associated with potassium channel and ROS pathways. It was hypothesized that pulegone first inhibits ROS signaling, to then inhibit NLRP3 expression as a downstream event. It appeared that NLRP3 may be situated further downstream and represented the link between inflammation and immunity.

View Figures

View References

1	He L, Wang T, Chen BW, Lu FM and Xu J: Puerarin inhibits apoptosis and inflammation in myocardial cells via PPARα expression in rats with chronic heart failure. Exp Ther Med. 18:3347–3356. 2019.PubMed/NCBI
2	Gan WQ, Man SF, Senthilselvan A and Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax. 59:574–580. 2004. View Article : Google Scholar : PubMed/NCBI
3	Awan Z and Genest J: Inflammation modulation and cardiovascular disease prevention. Eur J Prev Cardiol. 22:719–733. 2015. View Article : Google Scholar : PubMed/NCBI
4	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
5	Kawabori M and Yenari MA: Inflammatory responses in brain ischemia. Curr Med Chem. 22:1258–1277. 2015. View Article : Google Scholar : PubMed/NCBI
6	Amor S, Puentes F, Baker D and van der Valk P: Inflammation in neurodegenerative diseases. Immunology. 129:154–169. 2010. View Article : Google Scholar : PubMed/NCBI
7	Biondi-Zoccai GG, Abbate A, Liuzzo G and Biasucci LM: Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol. 41:1071–1077. 2003. View Article : Google Scholar : PubMed/NCBI
8	Zheng Z and Zheng F: Immune cells and inflammation in diabetic nephropathy. J Diabetes Res. 2016:18416902016. View Article : Google Scholar : PubMed/NCBI
9	Clevers H: At the crossroads of inflammation and cancer. Cell. 118:671–674. 2004. View Article : Google Scholar : PubMed/NCBI
10	Gupta RA and Dubois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 1:11–21. 2001. View Article : Google Scholar : PubMed/NCBI
11	Balkwill F and Coussens LM: Cancer: An inflammatory link. Nature. 431:405–406. 2004. View Article : Google Scholar : PubMed/NCBI
12	Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 431:461–466. 2004. View Article : Google Scholar : PubMed/NCBI
13	Adlard ER: Handbook of Essential Oils. Science, Technology and Applications. Chromatographia. 72:10212010. View Article : Google Scholar
14	Chen F, Wei G, Xu J, Ma H and Wang Q: Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome. BMC Complementary Alternative Med. 18:1922018. View Article : Google Scholar
15	Li ZJ, Choi DK, Sohn KC, Seo MS, Lee HE, Lee Y, Seo YJ, Lee YH, Shi G, Zouboulis CC, et al: Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol. 134:2747–2756. 2014. View Article : Google Scholar : PubMed/NCBI
16	Zhou R, Yazdi AS, Menu P and Tschopp J: A role for mitochondria in NLRP3 inflammasome activation. Nature. 469:221–225. 2011. View Article : Google Scholar : PubMed/NCBI
17	Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P and Tschopp J: T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature. 460:269–273. 2009. View Article : Google Scholar : PubMed/NCBI
18	Darisipudi MN, Thomasova D, Mulay SR, Brech D, Noessner E, Liapis H and Anders HJ: Uromodulin triggers IL-1β-dependent innateimmunity via the NLRP3 inflammasome. J Am Soc Nephrol. 23:1783–1789. 2012. View Article : Google Scholar : PubMed/NCBI
19	Xu F, Wen T, Wang F, Sang W and Zeng N: Protective effect of cinnamicaldehyde in endotoxin poisoning mice. Immunopharmacol Immunotoxicol. 38:455–463. 2016. View Article : Google Scholar : PubMed/NCBI
20	Kawata JK, Kameda M and Miyazawa M: Cyclooxygenase-2 inhibitory effects of monoterpenoids with a p-menthane skeleton. Int J Essent Oil Ther. 2:145–148. 2008.
21	Ortiz de Urbina AV, Martín ML, Montero MJ, Morán A and San Román L: Sedating and antipyretic activity of essential oil of Calamintha sylvatica subsp. Ascendens J Ethnopharmacol. 25:165–171. 1989. View Article : Google Scholar : PubMed/NCBI
22	Ruberto G and Baratta MT: Antioxidant activity of selected essential oil components in two lipid model systems. Food Chem. 69:167–174. 2000. View Article : Google Scholar
23	Ryan MF and Byrne O: Plant-insect coevolution and inhibition of acetylcholinesterase. J Chem Ecol. 14:1965–1975. 1988. View Article : Google Scholar : PubMed/NCBI
24	Miyazawa M, Watanabe H and Kameoka H: Inhibition of acetylcholinesterase activity by monoterpenoids with a p-menthane skeleton. J Agric Food Chem. 45:677–679. 1997. View Article : Google Scholar
25	Demirci B, Temel HE, Portakal T, Kırmızıbekmez H, Demirci F and Başer KHC: Inhibitory effect of Calamintha nepeta subsp. glandulosa essential oil on lipoxygenase. Turk J Biochem. 36:290–295. 2011.
26	Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, et al: Molecular cloning of the interleukin-1 beta converting enzyme. Science. 256:97–100. 1992. View Article : Google Scholar : PubMed/NCBI
27	Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 356:768–774. 1992. View Article : Google Scholar : PubMed/NCBI
28	Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, et al: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 386:619–623. 1997. View Article : Google Scholar : PubMed/NCBI
29	Skeldon AM, Faraj M and Saleh M: Caspases and inflammasomes in metabolic inflammation. Immunol Cell Biol. 92:304–313. 2014. View Article : Google Scholar : PubMed/NCBI
30	Tack CJ, Stienstra R, Joosten LA and Netea MG: Inflammation links excess fat to insulin resistance: The role of the interleukin-1 family. Immunol Rev. 249:239–252. 2012. View Article : Google Scholar : PubMed/NCBI
31	Martinon F, Burns K and Tschopp J: The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 10:417–426. 2002. View Article : Google Scholar : PubMed/NCBI
32	Vanaja SK, Rathinam VA and Fitzgerald KA: Mechanisms of inflammasome activation: Recent advances and novel insights. Trends Cell Biol. 25:308–315. 2015. View Article : Google Scholar : PubMed/NCBI
33	Jo EK, Kim JK, Shin DM and Sasakawa C: Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 13:148–159. 2016. View Article : Google Scholar : PubMed/NCBI
34	He Y, Zeng MY, Yang D, Motro B and Núñez G: NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 530:354–357. 2016. View Article : Google Scholar : PubMed/NCBI
35	Rivers-Auty J and Brough D: Potassium efflux fires the canon: Potassium efflux as a common trigger for canonical and noncanonical NLRP3 pathways. Eur J Immunol. 45:2758–2761. 2015. View Article : Google Scholar : PubMed/NCBI
36	Rühl S and Broz P: Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol. 45:2927–2936. 2015. View Article : Google Scholar : PubMed/NCBI
37	Segovia J, Sabbah A, Mgbemena V, Tsai SY, Chang TH, Berton MT, Morris IR, Allen IC, Ting JP and Bose S: TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One. 7:e296952012. View Article : Google Scholar : PubMed/NCBI
38	Muñoz-Planillo R, Kuffa P, Martníez-Colón G, Smith BL, Rajendiran TM and Núñez G: K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 38:1142–1153. 2013. View Article : Google Scholar : PubMed/NCBI
39	Wang F, Xu F, Wen T, et al: Effect of essential oil from Schizonepeta tenuifolia on the mechanism of NLRP3 inflammasome activation in THP-1 cells. J Chin Med Materials. 40:689–694. 2017.(In Chinese).